sspina@olonspa.it<\/a> \u2013 mobile 338.6674289<\/p>\nOlon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.<\/p>\n
With one of the longest track records of the API industry, having deep development expertise and a broad set of advanced technologies, we are the partner of choice which enables our client’s molecules to enter the market successfully.<\/p>\n
Olon has a global network of 11 manufacturing sites and 7 R&D centers across the globe. Thanks to our 2,300 employees, including 300 highly experienced and qualified R&D experts, we represent a highly innovative and reliable partner.<\/p>\n
At Olon, expertise and competent flexibility throughout the organization help build successful outcomes for our clients in custom chemical synthesis and microbial fermentation, while always maintaining the highest levels of safety, quality, and environmental compliance.<\/p>\n
A photo accompanying this announcement is available at https:\/\/www.globenewswire.com\/ NewsRoom\/AttachmentNg\/ 6114c829-f3f0-4f92-8b93- 9f42b6c4c8b0<\/a> <\/p>\nGlobeNewswire Distribution ID 1000822609<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"
OLON ENTERS IN ADC MARKET MILAN, Italy, May 30, 2023 (GLOBE NEWSWIRE) \u2014 OLON Group, a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and general markets, announces the start of construction of a new facility at its Rodano site (Milan, Italy) which will be entirely dedicated to managing [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\n
OLON Enters in ADC Market - Myanmar Newswire<\/title>\n \n \n \n \n \n \n \n \n \n \n \n \n \n\t \n\t \n\t \n